Skip to main content
HR 2038 116th Congress House

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

Official title: To allow State-based, market-oriented, prescription drug negotiations to lower pharmaceutical drug prices, to encourage competition, to increase consumer choice and access, and for other purposes.

Introduced: April 2, 2019 See on congress.gov
Health CancerChild healthChild safety and welfareCongressional oversight
More subjectsShow fewer subjects
Drug, alcohol, tobacco useHealth care costs and insuranceHealth care coverage and accessHealth facilities and institutionsHealth personnelHealth programs administration and fundingLong-term, rehabilitative, and terminal carePrescription drugsRural conditions and developmentSales and excise taxesState and local finance
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 15, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Apr 2, 2019
Referred to the House Committee on the Judiciary.
Apr 2, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 15, 2019

Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

 Plain-English summary Congressional Research Service

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.

 Related & companion bills 2
  • S 4796 Related bill Fair Care Act of 2020
  • HR 8527 Related bill Fair Care Act of 2020
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1
R
Budd, Ted
North Carolina · Apr 15, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2038: State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-2038/
MLA
"H.R. 2038: State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-2038/.
Bluebook (legal)
H.R. 2038, 116th Cong. (2026), https://openamerica.io/bill/116-HR-2038/.
Markdown link
[H.R. 2038: State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019](https://openamerica.io/bill/116-HR-2038/)
Report a problem